<DOC>
	<DOC>NCT00488241</DOC>
	<brief_summary>To show efficacy of Zarzenda in the treatment of hand eczema</brief_summary>
	<brief_title>Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema</brief_title>
	<detailed_description>The objective of the study is to demonstrate efficacy and safety of Zarzenda (a medical device) in the management of hand eczema.</detailed_description>
	<mesh_term>Eczema</mesh_term>
	<criteria>Mild to moderate hand eczema for at least 3 months At least 4 weeks have passed since use of systemic treatment for eczema At least 4 weeks have passed since any vaccination At least 1 week has passed since last topic treatment on hands with corticosteroids Agree to use adequate contraceptive method if of childbearing potential Willingness to avoid excessive exposure to sunlight and avoid skin irritants Pregnancy, breast feeding Severe excoriations on the hands Need for systemic treatment for atopic dermatitis Known sensitivity to Zarzenda and/or to extract of nut butyrospermum parkii (shea) Known immune deficiency Concomitant infection on hands</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Eczema</keyword>
	<keyword>Medical device</keyword>
</DOC>